SESSA, FRANCESCA
SESSA, FRANCESCA
DIPARTIMENTO DI SANITA' PUBBLICA
Local ablative therapy of oligoprogressive TKI-treated thyroid cancer
2019 Porcelli, T.; Sessa, Francesca; Luongo, C.; Salvatore, Domenico
Management of one patient with oligoprogressive thyroid cancer during treatment with lenvatinib
2019 Porcelli, T.; Sessa, F.; Gambale, Carla; Luongo, C.; Salvatore, Domenico
Teriparatide replacement therapy for hypoparathyroidism during treatment with lenvatinib for advanced thyroid cancer: A case report
2018 Porcelli, T.; Sessa, F.; Caputo, A.; Catalini, C.; Salvatore, Domenico
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution
2021 Porcelli, T.; Luongo, C.; Sessa, F.; Klain, M.; Masone, S.; Troncone, G.; Bellevicine, C.; Schlumberger, M.; Salvatore, D.
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report
2021 Luongo, C.; Porcelli, T.; Sessa, F.; De Stefano, M. A.; Scavuzzo, F.; Damiano, V.; Klain, M.; Bellevicine, C.; Matano, E.; Troncone, G.; Schlumberger, M.; Salvatore, D.
Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy
2021 Luongo, C; Morra, R; Gambale, C; Porcelli, T; Sessa, F; Matano, E; Damiano, V; Klain, M; Schlumberger, M; Salvatore, D
The Impact of Thyroid Diseases on Patients' Work Functioning: A Pilot Study
2022 Vetrani, I.; Leso, V.; Fontana, L.; Vetrani, C.; Spadarella, E.; Sessa, F.; Porcelli, T.; Iavicoli, I.
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
Local ablative therapy of oligoprogressive TKI-treated thyroid cancer | 1.1 Articolo in rivista | 2019 | Porcelli, T.; Sessa, Francesca; Luongo, C.; Salvatore, Domenico | |
Management of one patient with oligoprogressive thyroid cancer during treatment with lenvatinib | 1.1 Articolo in rivista | 2019 | Porcelli, T.; Sessa, F.; Gambale, Carla; Luongo, C.; Salvatore, Domenico | |
Teriparatide replacement therapy for hypoparathyroidism during treatment with lenvatinib for advanced thyroid cancer: A case report | 1.1 Articolo in rivista | 2018 | Porcelli, T.; Sessa, F.; Caputo, A.; Catalini, C.; Salvatore, Domenico | |
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution | 1.1 Articolo in rivista | 2021 | Porcelli, T.; Luongo, C.; Sessa, F.; Klain, M.; Masone, S.; Troncone, G.; Bellevicine, C.; Schlumberger, M.; Salvatore, D. | |
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report | 1.1 Articolo in rivista | 2021 | Luongo, C.; Porcelli, T.; Sessa, F.; De Stefano, M. A.; Scavuzzo, F.; Damiano, V.; Klain, M.; Bellevicine, C.; Matano, E.; Troncone, G.; Schlumberger, M.; Salvatore, D. | |
Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy | 1.1 Articolo in rivista | 2021 | Luongo, C; Morra, R; Gambale, C; Porcelli, T; Sessa, F; Matano, E; Damiano, V; Klain, M; Schlumberger, M; Salvatore, D | |
The Impact of Thyroid Diseases on Patients' Work Functioning: A Pilot Study | 1.1 Articolo in rivista | 2022 | Vetrani, I.; Leso, V.; Fontana, L.; Vetrani, C.; Spadarella, E.; Sessa, F.; Porcelli, T.; Iavicoli, I. |